200 related articles for article (PubMed ID: 35227909)
1. Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the International Association for the Study of Lung Cancer Grading System.
Fujikawa R; Muraoka Y; Kashima J; Yoshida Y; Ito K; Watanabe H; Kusumoto M; Watanabe SI; Yatabe Y
J Thorac Oncol; 2022 May; 17(5):700-707. PubMed ID: 35227909
[TBL] [Abstract][Full Text] [Related]
2. Micropapillary and solid components as high-grade patterns in IASLC grading system of lung adenocarcinoma: Clinical implications and management.
Mikubo M; Tamagawa S; Kondo Y; Hayashi S; Sonoda D; Naito M; Shiomi K; Ichinoe M; Satoh Y
Lung Cancer; 2024 Jan; 187():107445. PubMed ID: 38157805
[TBL] [Abstract][Full Text] [Related]
3. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
[No Abstract] [Full Text] [Related]
4. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):607-12. PubMed ID: 22104678
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
[TBL] [Abstract][Full Text] [Related]
7. Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.
Woo W; Cha YJ; Kim BJ; Moon DH; Lee S
Clin Lung Cancer; 2022 Nov; 23(7):e435-e442. PubMed ID: 35945128
[TBL] [Abstract][Full Text] [Related]
8. Validation of the novel International Association for the Study of Lung Cancer grading system and prognostic value of filigree micropapillary and discohesive growth pattern in invasive pulmonary adenocarcinoma.
Zhang Y; Zhang Y; Hu Y; Zhang S; Zhu M; Hu B; Guo X; Lu J; Zhang Y
Lung Cancer; 2023 Jan; 175():79-87. PubMed ID: 36481678
[TBL] [Abstract][Full Text] [Related]
9. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.
Kadota K; Suzuki K; Kachala SS; Zabor EC; Sima CS; Moreira AL; Yoshizawa A; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Mod Pathol; 2012 Aug; 25(8):1117-27. PubMed ID: 22499226
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Novel International Association for the Study of Lung Cancer Grading System for Invasive Pulmonary Adenocarcinoma and Association With Common Driver Mutations.
Deng C; Zheng Q; Zhang Y; Jin Y; Shen X; Nie X; Fu F; Ma X; Ma Z; Wen Z; Wang S; Li Y; Chen H
J Thorac Oncol; 2021 Oct; 16(10):1684-1693. PubMed ID: 34302987
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance and grading of stromal invasion in pT1 adenocarcinoma of lung].
Xu Y; Zhou XJ; Dong YC; Ma HH; Lu ZF; He Y
Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):451-5. PubMed ID: 19781191
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of the Proposed Pathologic Criteria for Invasion by the International Association for the Study of Lung Cancer in Resected Nonmucinous Lung Adenocarcinoma.
Hong TH; Hwang S; Cho J; Choi YL; Han J; Lee G; Jeon YJ; Lee J; Park SY; Cho JH; Choi YS; Kim J; Shim YM; Kim HK
J Thorac Oncol; 2024 Mar; 19(3):425-433. PubMed ID: 37924973
[TBL] [Abstract][Full Text] [Related]
13. Clinical implication of the 2020 International Association for the Study of Lung Cancer histologic grading in surgically resected pathologic stage 1 lung adenocarcinomas: Prognostic value and association with computed tomography characteristics.
Cho IS; Shim HS; Lee HJ; Suh YJ
Lung Cancer; 2023 Oct; 184():107345. PubMed ID: 37611496
[TBL] [Abstract][Full Text] [Related]
14. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.
Moreira AL; Ocampo PSS; Xia Y; Zhong H; Russell PA; Minami Y; Cooper WA; Yoshida A; Bubendorf L; Papotti M; Pelosi G; Lopez-Rios F; Kunitoki K; Ferrari-Light D; Sholl LM; Beasley MB; Borczuk A; Botling J; Brambilla E; Chen G; Chou TY; Chung JH; Dacic S; Jain D; Hirsch FR; Hwang D; Lantuejoul S; Lin D; Longshore JW; Motoi N; Noguchi M; Poleri C; Rekhtman N; Tsao MS; Thunnissen E; Travis WD; Yatabe Y; Roden AC; Daigneault JB; Wistuba II; Kerr KM; Pass H; Nicholson AG; Mino-Kenudson M
J Thorac Oncol; 2020 Oct; 15(10):1599-1610. PubMed ID: 32562873
[TBL] [Abstract][Full Text] [Related]
15. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
Mimae T; Miyata Y; Mimura T; Ito H; Nakayama H; Okumura S; Yoshimura M; Okada M
Jpn J Clin Oncol; 2015 Aug; 45(8):767-73. PubMed ID: 26056324
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.
Yang F; Chen K; Liao Y; Li X; Sun K; Bao D; Wang J
World J Surg Oncol; 2014 Sep; 12():285. PubMed ID: 25216551
[TBL] [Abstract][Full Text] [Related]
17. Novel Insights Into the International Association for the Study of Lung Cancer Grading System for Lung Adenocarcinoma.
Tan KS; Reiner A; Emoto K; Eguchi T; Takahashi Y; Aly RG; Rekhtman N; Adusumilli PS; Travis WD
Mod Pathol; 2024 May; 37(7):100520. PubMed ID: 38777035
[TBL] [Abstract][Full Text] [Related]
18. A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination.
Bossé Y; Gagné A; Althakfi WA; Orain M; Couture C; Trahan S; Pagé S; Joubert D; Fiset PO; Desmeules P; Joubert P
Am J Surg Pathol; 2023 Jun; 47(6):686-693. PubMed ID: 37032554
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features.
Ma Z; Zhang Y; Deng C; Fu F; Deng L; Li Y; Chen H
J Thorac Cardiovasc Surg; 2022 Jan; 163(1):e73-e85. PubMed ID: 32739163
[TBL] [Abstract][Full Text] [Related]
20. The new IASLC grading system for invasive non-mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems.
Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
J Surg Oncol; 2023 Jan; 127(1):174-182. PubMed ID: 36098331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
